-
Bipolar Disorder Mood Stabilizers Market to Reach USD 2.64 Billion by 2032, Backed by Advances in Mood Stabilizing Drug Development
13 May 2025 20:55 GMT
… opt for different
medications, including mood … antidepressants or antipsychotics to manage symptoms more effectively.
Ø Continuous new drug … FDA approved Vanda Pharmaceutical’s drug for the treatment …
Risperidone
Lurasidone
Ziprasidone
Asenapine
Calcium …
-
Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial
09 May 2025 18:33 GMT
… intention-to-treat trial (MIND-USA) conducted at 16 medical centers in … treatment groups: haloperidol, 458.0 ms (IQR, 432.0-479.0); ziprasidone … 1 day after study drug receipt (1 ziprasidone recipient), and ventricular fibrillation …
-
Cobenfy Did Not Meet Primary Outcome as Add-On Treatment for Schizophrenia
24 Apr 2025 20:54 GMT
… 1
"Adjunctive treatment trials in schizophrenia present … acting injectables, such as ziprasidone, lurasidone, or cariprazine … vice president, chief medical officer, and head … Drug Approved by FDA Represents First New Treatment Option in Decades. Drug …
-
Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia
22 Apr 2025 20:48 GMT
… paliperidone, aripiprazole, ziprasidone, lurasidone and … "Adjunctive treatment trials in schizophrenia … medical conference.
Bristol Myers Squibb thanks the patients, investigators and clinical trial … commercialization of pharmaceutical products. All …
-
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
05 Apr 2025 08:44 GMT
… blind, placebo-controlled trials of nearly identical … Drug Administration (FDA) awarded xanomeline/trospium approval for the treatment … , and Takeda Pharmaceuticals. The authors … week placebo-controlled trial. Ziprasidone Study Group. …
-
Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment
01 Apr 2025 15:14 GMT
… level of medical care. Maintenance treatment also include … )
Risperidone (Risperdal; Janssen Pharmaceuticals, Inc)
Ziprasidone (Geodon; Pfizer)
LAIs … .
Unlike the oral pill burden, LAIs can … #47;fda-approves-drug-new-mechanism-action-treatment-schizophrenia?os …
-
FDA Approved Drug Products Approval List January 2025
11 Mar 2025 11:43 GMT
Approval Date Drug Name Submission Active … GEODONNDA #020825 SUPPL-65 ZIPRASIDONE HYDROCHLORIDE VIATRIS Labeling Approval … #020919 SUPPL-53 ZIPRASIDONE MESYLATE VIATRIS Labeling Approval … #761036 SUPPL-51 DARATUMUMAB JANSSEN BIOTECH Approval 01/24 …
-
Global Schizophrenia Drugs Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, Emerging Trends
27 Feb 2025 17:44 GMT
… Pharmaceutical Co. Ltd., Reviva Pharmaceuticals Holdings Inc., Lifegenix, Flagship Biotech … medication for schizophrenia, in a bid to enhance patient treatment … , Aripiprazole, Paliperidone, Ziprasidone, Others
2 By … Of Schizophrenia Drugs Market?
North …
-
Doctor warns taking tablets with popular breakfast fruit could be 'dangerous'- risk of organ failure
12 Feb 2025 11:48 GMT
… cholesterol medication statins, blood pressure medication, psychiatric medication, … herbal remedies with medications can cause … Ziprasidone
Nausea drugs
Immunosuppressants
Cyclosporine
Everolimus
Sirolimus
Tacrolimus
Urinary tract medications …
-
Acute Agitation and Aggression Treatment Market to Exceed USD 8.2 Billion by 2034, Driven by Advancements in Rapid-Acting Therapies - Latest Report by Transparency Market Research Inc.
06 Feb 2025 12:50 GMT
… the demand for acute agitation treatments.
Pharmaceutical Innovations: Major players in … Anti-Psychotics
Quetiapine
Olanzapine
Ziprasidone
Benzodiazepines
Alpha-2 Adrenergic …
Bipolar Disorder
Dementia
Depression
Drug-induced agitation and aggression
…
About
© 1995-2025